Gossamer Bio, Inc. - 8-K Filing
Gossamer Bio filed an exchange offer for its $50 million 5.00% convertible senior notes due 2027, offering up to $72 million in new 7.50% convertible senior secured first lien notes due 2030, along with shares or warrants. The company also announced a consent solicitation to amend the indenture of existing notes by removing restrictive covenants and events of default. (Items: 1.01 Entry into a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure)
Tickers: $GOSS